| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 10/03/2001 | CN1315999A Genetic method for expression of polyproteins in plants |
| 10/03/2001 | CN1315998A Compositions and methods for therapy and diagnosis of prostate cancer |
| 10/03/2001 | CN1315966A High-affinity antibodies |
| 10/03/2001 | CN1315342A Novel human As resistance related protein and its coding sequence |
| 10/03/2001 | CA2343488A1 Test methods and devices |
| 10/03/2001 | CA2342683A1 Test methods and devices |
| 10/02/2001 | US6297364 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 10/02/2001 | US6297361 Use of histidine decarboxylase immunoreactivity to detect human cancer |
| 10/02/2001 | US6297359 Polypeptide for use in the treatment of diabetes, dietetics, hypertension and premature atherosclerosis |
| 10/02/2001 | US6297220 Recombinant adenovirus comprising a dna sequence that codes for a gene product is delivered to a cardiac or vascular smooth muscle cell and the cell is maintained until that gene product is expressed. |
| 10/02/2001 | US6297213 Osteogenic devices |
| 10/02/2001 | US6297053 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 10/02/2001 | US6297052 Cell culture; for use in proliferation of preferential compounds in cells |
| 10/02/2001 | US6297049 Methods and compositions for ameliorating the symptoms of sepsis |
| 10/02/2001 | US6297042 Cheese making with bacteriophage resistant bacteria |
| 10/02/2001 | US6297035 Extracellular signal regulated kinase; for the treatment of alzheimer's and diabeties |
| 10/02/2001 | US6297029 Mammalian artificial chromosomes |
| 10/02/2001 | US6297028 IL-2R-associated polypeptide and DNA molecules coding therefor |
| 10/02/2001 | US6296853 For therapy of animal having a papilloma viral infection |
| 10/02/2001 | US6296851 For screening antibiotics |
| 10/02/2001 | CA2148223C Bacteriocins from streptococcus thermophilus |
| 10/02/2001 | CA1341299C Mammalian interleukin-4 |
| 09/27/2001 | WO2001071017A2 Modified nodavirus rna for gene delivery |
| 09/27/2001 | WO2001071005A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | WO2001071004A2 Proteases |
| 09/27/2001 | WO2001070984A2 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 09/27/2001 | WO2001070978A2 Polypeptides and nucleic acids encoding same |
| 09/27/2001 | WO2001070977A2 Fibroblast growth factor receptor-like molecules and uses thereof |
| 09/27/2001 | WO2001070975A1 Novel melanin concentrating hormone receptor |
| 09/27/2001 | WO2001070968A2 Production of recombinant blood clotting factors in human cell lines |
| 09/27/2001 | WO2001070955A2 Identification of essential genes in prokaryotes |
| 09/27/2001 | WO2001070952A1 Human gata-5 transcription factor |
| 09/27/2001 | WO2001070811A1 Potassium channel protein kcnq5, a target for diseases of central nervous system and cardiovascular system |
| 09/27/2001 | WO2001070807A2 G-protein associated molecules |
| 09/27/2001 | WO2001070804A1 7 human ovarian and ovarian cancer associated proteins |
| 09/27/2001 | WO2001070799A1 Novel protein having hemolytic activity and gene encoding the protein |
| 09/27/2001 | WO2001070798A2 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 09/27/2001 | WO2001070797A1 Ligand-controlled anion channels of insects |
| 09/27/2001 | WO2001070771A2 Acute neuronal induced calcium binding protein type 1 ligand |
| 09/27/2001 | WO2001070267A1 Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use |
| 09/27/2001 | WO2001070261A1 Sperm factor oscillogenin |
| 09/27/2001 | WO2001070255A2 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 09/27/2001 | WO2001070173A2 Immunokine composition and method |
| 09/27/2001 | WO2001070031A1 Opioid growth factor modulates angiogenesis |
| 09/27/2001 | WO2001019992A3 FACTOR IX/FACTOR IXa ANTIBODIES AND ANTIBODY DERIVATIV ES |
| 09/27/2001 | WO2001018546A3 Screening for inhibitors of 'paired helical filaments' |
| 09/27/2001 | WO2001016170A3 Card proteins involved in cell death regulation |
| 09/27/2001 | WO2001014533A3 Phosphomevalonate kinase (pmk) gene (erg8) from candida albicans |
| 09/27/2001 | WO2001009178A3 Human chaperone proteins |
| 09/27/2001 | US20010024817 Viral nucleotide sequences |
| 09/27/2001 | US20010024813 Human dendriac and brainiac-3 |
| 09/27/2001 | US20010024807 Polynucleotides encoding crippled selectable marker such as neomycin resistance; heterologous polypeptides of interest; amplifiable selectable marker such as dehydrofolate reductase |
| 09/27/2001 | US20010024783 By administering a heat and RnaseH resistant antisense agent and detecting the presence in a body fluid sample of a nuclease-resistant heteroduplex of the antisense oligomer and the target RNA; detecting infective agents, pregnancy |
| 09/27/2001 | US20010024650 Artery - and vein-specific proteins and uses therefor |
| 09/27/2001 | US20010024648 Four monkey monoclonal antibodies 7B6, 16C10, 7C10 and 20C9 which inhibit the B7:CD28 pathway and thereby function as effeftive immunosuppressants for the treatment of autoimmune diseases and prevent organ trasplant rejection |
| 09/27/2001 | US20010024647 Single chain variable region immunoglobulin (ScFv) fragment antibody that binds selectively to the active conformation of human von Willebrand Factor (vWF) and the antibody inhibits the binding of vWF to platelets |
| 09/27/2001 | DE10014997A1 Production of chitin comprises demineralizing and deproteinizing a chitin-containing material in the presence of a biodegradable complexing agent and a protease |
| 09/27/2001 | DE10013732A1 New DNA sequence encoding potassium channel KCNQ5, useful in screening for specific modulators, potential agents for treating central nervous system and cardiovascular diseases |
| 09/27/2001 | CA2406993A1 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | CA2404260A1 Identification of essential genes in prokaryotes |
| 09/27/2001 | CA2404078A1 Immunokine composition and method |
| 09/27/2001 | CA2403572A1 Fibroblast growth factor receptor-like molecules and uses thereof |
| 09/27/2001 | CA2403436A1 Acute neuronal induced calcium binding protein type 1 ligand |
| 09/27/2001 | CA2403434A1 Human gata-5 transcription factor |
| 09/27/2001 | CA2403359A1 Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use |
| 09/27/2001 | CA2402763A1 Proteases |
| 09/27/2001 | CA2402747A1 G-protein associated molecules |
| 09/27/2001 | CA2402722A1 Sperm factor oscillogenin |
| 09/27/2001 | CA2402596A1 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 09/27/2001 | CA2401887A1 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 09/27/2001 | CA2400638A1 7 human ovarian and ovarian cancer associated proteins |
| 09/27/2001 | CA2374073A1 Novel polypeptides and nucleic acids encoding same |
| 09/26/2001 | EP1136556A1 Multivalent antigen-binding proteins |
| 09/26/2001 | EP1136548A1 Novel trypsin family serine proteases |
| 09/26/2001 | EP1136547A2 Adamts polypeptides, nucleic acids encoding them, and uses thereof |
| 09/26/2001 | EP1136504A1 Receptor for Latrotoxin from insects |
| 09/26/2001 | EP1136503A1 Novel physiologically active substance, process for producing the same and utilization thereof |
| 09/26/2001 | EP1136502A1 Insect ligand-gated anion channels |
| 09/26/2001 | EP1136501A2 Receptors for peptides from insect origin |
| 09/26/2001 | EP1136500A2 Seroreactive regions from the HPV proteins E1 and E2 |
| 09/26/2001 | EP1135687A1 An immunoassay for the determination of transmissible spongiform encephalopathies in mammals |
| 09/26/2001 | EP1135532A1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof |
| 09/26/2001 | EP1135509A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/26/2001 | EP1135504A2 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 09/26/2001 | EP1135501A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/26/2001 | EP1135498A1 Antibody variants with higher binding affinity compared to parent antibodies |
| 09/26/2001 | EP1135496A2 Ucp5 |
| 09/26/2001 | EP1135495A2 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
| 09/26/2001 | EP1135494A2 Neuron-associated proteins |
| 09/26/2001 | EP1135491A2 Methods and compositions for inhibiting neoplastic cell growth |
| 09/26/2001 | EP1135490A1 Human vanilloid receptors and their uses |
| 09/26/2001 | EP1135489A1 Pth1r and pth3r receptors |
| 09/26/2001 | EP1135485A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/26/2001 | EP1135484A2 Gtpase associated proteins |
| 09/26/2001 | EP1135483A2 Cytokine signal regulators |
| 09/26/2001 | EP1135482A1 Cancer cell vaccine |
| 09/26/2001 | EP1135477A1 Humanized monoclonal antibodies |
| 09/26/2001 | EP1135467A1 Psca: prostate stem cell antigen and uses thereof |
| 09/26/2001 | EP1135412A2 Tumor necrosis factor receptor homologue-1 (trh1) |
| 09/26/2001 | EP1135407A1 Ring finger protein zapop3 |